Century Therapeutics Stock Price on December 11, 2024

IPSC Stock  USD 1.02  0.08  7.27%   
If you're considering investing in Century Stock, it is important to understand the factors that can impact its price. As of today, the current price of Century Therapeutics stands at 1.02, as last reported on the 25th of December, with the highest price reaching 1.03 and the lowest price hitting 0.95 during the day. Century Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0921, which signifies that the company had a -0.0921% return per unit of risk over the last 3 months. Century Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Century Therapeutics' Risk Adjusted Performance of (0.07), mean deviation of 4.06, and Standard Deviation of 5.32 to double-check the risk estimate we provide.
  
At present, Century Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.4 M, whereas Common Stock Total Equity is forecasted to decline to 3,575. . At present, Century Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.12, whereas Price To Sales Ratio is forecasted to decline to 58.04. Century Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0921

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIPSC

Estimated Market Risk

 5.43
  actual daily
48
52% of assets are more volatile

Expected Return

 -0.5
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Century Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Century Therapeutics by adding Century Therapeutics to a well-diversified portfolio.
Price Book
0.4432
Enterprise Value Ebitda
0.0752
Price Sales
32.472
Shares Float
28.6 M
Wall Street Target Price
9.6667

Related Headline

Mineralys Therapeutics, Headline on 11th of December 2024

Filed transaction by Mineralys Therapeutics, Common Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Century Therapeutics Valuation on December 11, 2024

It is possible to determine the worth of Century Therapeutics on a given historical date. On December 11, 2024 Century was worth 1.4 at the beginning of the trading date compared to the closed value of 1.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Century Therapeutics stock. Still, in general, we apply an absolute valuation method to find Century Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Century Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Century Therapeutics' related companies.
 Open High Low Close Volume
  1.51    1.62    1.36    1.41    993,424  
12/11/2024
  1.40    1.43    1.33    1.35    788,208  
  1.37    1.38    1.24    1.25    1,017,443  
Backtest Century Therapeutics  |  Century Therapeutics History  |  Century Therapeutics Valuation   PreviousNext  
Open Value
1.4
1.35
Closing Value
17.69
Upside

Century Therapeutics Trading Date Momentum on December 11, 2024

On December 12 2024 Century Therapeutics was traded for  1.25  at the closing time. The top price for the day was 1.38  and the lowest listed price was  1.24 . The trading volume for the day was 1 M. The trading history from December 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.41% . The overall trading delta against the current closing price is 17.78% .

Century Therapeutics Fundamentals Correlations and Trends

By evaluating Century Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Century Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Century financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Century Therapeutics Stock history

Century Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Century is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Century Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Century Therapeutics stock prices may prove useful in developing a viable investing in Century Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding59.3 M62 M
Net Loss-150.6 M-158.1 M

Century Therapeutics Quarterly Net Working Capital

186.19 Million

Century Therapeutics Stock Technical Analysis

Century Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Century Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Century Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Century Therapeutics Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Century Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Century Therapeutics December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns

Century Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Century Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Century Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Century to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Century Stock analysis

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Share Portfolio
Track or share privately all of your investments from the convenience of any device